Shanghai INT Medical Instruments Co (HKSE:01501) Debt-to-Equity

: 0.06 (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

Shanghai INT Medical Instruments Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$86.5 Mil. Shanghai INT Medical Instruments Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$17.1 Mil. Shanghai INT Medical Instruments Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$1,803.9 Mil. Shanghai INT Medical Instruments Co's debt to equity for the quarter that ended in Dec. 2023 was 0.06.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Shanghai INT Medical Instruments Co's Debt-to-Equity or its related term are showing as below:

HKSE:01501' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.02 Max: 0.16
Current: 0.06

During the past 8 years, the highest Debt-to-Equity Ratio of Shanghai INT Medical Instruments Co was 0.16. The lowest was 0.00. And the median was 0.02.

HKSE:01501's Debt-to-Equity is ranked better than
77% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs HKSE:01501: 0.06

Shanghai INT Medical Instruments Co Debt-to-Equity Historical Data

The historical data trend for Shanghai INT Medical Instruments Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai INT Medical Instruments Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.03

0.06

Shanghai INT Medical Instruments Co Semi-Annual Data
	Dec16	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial								0.01	0.01	0.03	0.07	0.06

Competitive Comparison

For the Medical Instruments & Supplies subindustry, Shanghai INT Medical Instruments Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shanghai INT Medical Instruments Co Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Shanghai INT Medical Instruments Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Shanghai INT Medical Instruments Co's Debt-to-Equity falls into.

Shanghai INT Medical Instruments Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Shanghai INT Medical Instruments Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(86.543	+	17.124)	/	1803.905
	=	0.06

Shanghai INT Medical Instruments Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(86.543	+	17.124)	/	1803.905
	=	0.06

Shanghai INT Medical Instruments Co (HKSE:01501) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Shanghai INT Medical Instruments Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Shanghai INT Medical Instruments Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai INT Medical Instruments Co (HKSE:01501) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Shanghai INT Medical Instruments Co Ltd (HKSE:01501) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 925 Jin Yuan Yi Road, Block 2, Jiading District, Shanghai, CHN, 201803

Website

https://www.kdl-int.com

Shanghai INT Medical Instruments Co Ltd formerly Shanghai Kindly Medical Instruments Co Ltd is a manufacturer of cardiovascular interventional devices, which are mainly used in cardiovascular surgeries, and in particular, PCI procedures in China. It is engaged in the sales, manufacture, research, and development of cardiovascular interventional medical devices as well as related accessories and molds. It is also engaged in the research and development of other interventional and implantable medical devices, such as neurological interventional medical devices and endocardia implantable medical devices, among others. Geographically, it has operations in Mainland China, Europe, the United States, and Other countries.

Shanghai INT Medical Instruments Co (HKSE:01501) Headlines

No Headlines